『Unlocking the Malaysian MedTech Market: A Pure Global Deep Dive into the MDA Registration Process for ASEAN Success』のカバーアート

Unlocking the Malaysian MedTech Market: A Pure Global Deep Dive into the MDA Registration Process for ASEAN Success

Unlocking the Malaysian MedTech Market: A Pure Global Deep Dive into the MDA Registration Process for ASEAN Success

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 This episode of ASEAN MedTech Insights provides a detailed guide to navigating the medical device registration process with Malaysia's Medical Device Authority (MDA). We break down the essential steps for foreign manufacturers, from the critical appointment of a local Authorized Representative (AR) to understanding the four-tiered device classification system and the electronic submission process through the MeDC@St portal. We explore the detailed requirements for creating a Common Submission Dossier Template (CSDT) and the mandatory conformity assessments by CABs for higher-risk devices. For instance, a promising US-based scaleup developing a novel diagnostic tool faced significant setbacks. They underestimated the nuances of the MeDC@St system, leading to repeated submission rejections. Their chosen local AR lacked the specific expertise to guide them, delaying their market entry by nearly a year and allowing a competitor to gain a foothold. This highlights how procedural knowledge is as crucial as product innovation. Key Takeaways for This Episode: 1. Why is appointing a Malaysian Authorized Representative the non-negotiable first step for market entry? 2. How does Malaysia's risk-based classification (Class A to D) impact your registration timeline and costs? 3. What are the most common errors foreign manufacturers make when submitting documents via the MeDC@St online portal? 4. When is a review by a Conformity Assessment Body (CAB) required, and how does it differ from other regulatory audits? 5. What specific post-market surveillance activities are mandatory to maintain your device registration in Malaysia? 6. Can your existing CE Mark or FDA approval accelerate the MDA registration process? 7. What are the key legal responsibilities your Authorized Representative holds on your behalf? Pure Global offers end-to-end regulatory consulting to streamline this entire process. We combine local expertise with advanced AI tools to ensure your MedTech and IVD products achieve efficient market access in Malaysia and beyond. To learn how we can act as your local representative and manage your regulatory journey, contact us at info@pureglobal.com or visit https://pureglobal.com/.
まだレビューはありません